Home › Trial NCT00234000
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
- Trial IDNCT00234000
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorJonsson Comprehensive Cancer Center
- Enrollment1
- Start date2007-02
- ConditionsLeukemia · Myelodysplastic Syndromes
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.